NO316172B1 - 5,6-dihydropyron-derivater og farmasöytisk blanding - Google Patents
5,6-dihydropyron-derivater og farmasöytisk blanding Download PDFInfo
- Publication number
- NO316172B1 NO316172B1 NO19962017A NO962017A NO316172B1 NO 316172 B1 NO316172 B1 NO 316172B1 NO 19962017 A NO19962017 A NO 19962017A NO 962017 A NO962017 A NO 962017A NO 316172 B1 NO316172 B1 NO 316172B1
- Authority
- NO
- Norway
- Prior art keywords
- mmol
- hydroxy
- dihydro
- pyran
- prepared
- Prior art date
Links
- QBDAFARLDLCWAT-UHFFFAOYSA-N 2,3-dihydropyran-6-one Chemical class O=C1OCCC=C1 QBDAFARLDLCWAT-UHFFFAOYSA-N 0.000 title abstract description 22
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000011282 treatment Methods 0.000 claims abstract description 21
- 201000010099 disease Diseases 0.000 claims abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 11
- 150000001875 compounds Chemical class 0.000 claims description 243
- 239000000203 mixture Substances 0.000 claims description 49
- -1 2-isopropylphenyl Chemical group 0.000 claims description 40
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 17
- 208000015181 infectious disease Diseases 0.000 claims description 15
- 241001430294 unidentified retrovirus Species 0.000 claims description 13
- 241000700605 Viruses Species 0.000 claims description 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 8
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims description 2
- KJGFQJMJXRDFNI-UHFFFAOYSA-N 4-hydroxy-5-[(3-methoxyphenyl)methyl]-2-phenyl-2-(2-phenylethyl)-3h-pyran-6-one Chemical group COC1=CC=CC(CC=2C(OC(CCC=3C=CC=CC=3)(CC=2O)C=2C=CC=CC=2)=O)=C1 KJGFQJMJXRDFNI-UHFFFAOYSA-N 0.000 claims 1
- 229940125904 compound 1 Drugs 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 133
- 208000030507 AIDS Diseases 0.000 abstract description 11
- 108010017640 Aspartic Acid Proteases Proteins 0.000 abstract description 10
- 102000004580 Aspartic Acid Proteases Human genes 0.000 abstract description 10
- 230000015572 biosynthetic process Effects 0.000 abstract description 8
- 238000003786 synthesis reaction Methods 0.000 abstract description 7
- 238000011161 development Methods 0.000 abstract description 4
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 208000036142 Viral infection Diseases 0.000 abstract 1
- 230000001580 bacterial effect Effects 0.000 abstract 1
- 208000022362 bacterial infectious disease Diseases 0.000 abstract 1
- 230000000903 blocking effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 257
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 235
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 215
- 239000007787 solid Substances 0.000 description 128
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 122
- 238000005160 1H NMR spectroscopy Methods 0.000 description 121
- 238000006243 chemical reaction Methods 0.000 description 118
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 112
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 100
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 100
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 81
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 81
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 68
- 238000007429 general method Methods 0.000 description 62
- 239000000047 product Substances 0.000 description 58
- 238000005481 NMR spectroscopy Methods 0.000 description 57
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 54
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 54
- 239000000243 solution Substances 0.000 description 51
- 239000002904 solvent Substances 0.000 description 43
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 43
- 229910004298 SiO 2 Inorganic materials 0.000 description 41
- 238000004440 column chromatography Methods 0.000 description 41
- 238000000746 purification Methods 0.000 description 40
- 239000006185 dispersion Substances 0.000 description 38
- WRQNANDWMGAFTP-UHFFFAOYSA-N Methylacetoacetic acid Chemical compound COC(=O)CC(C)=O WRQNANDWMGAFTP-UHFFFAOYSA-N 0.000 description 37
- 239000012043 crude product Substances 0.000 description 34
- NPEQBQFWQFGATI-UHFFFAOYSA-N (4-methylphenyl)-oxo-phenylmethoxy-sulfanylidene-$l^{6}-sulfane Chemical compound C1=CC(C)=CC=C1S(=O)(=S)OCC1=CC=CC=C1 NPEQBQFWQFGATI-UHFFFAOYSA-N 0.000 description 31
- FDZPQUUHLRJKJL-UHFFFAOYSA-N (4-methylphenyl)-oxo-(2-phenylethoxy)-sulfanylidene-$l^{6}-sulfane Chemical compound C1=CC(C)=CC=C1S(=O)(=S)OCCC1=CC=CC=C1 FDZPQUUHLRJKJL-UHFFFAOYSA-N 0.000 description 29
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 26
- 229960000583 acetic acid Drugs 0.000 description 24
- 239000002253 acid Substances 0.000 description 23
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 23
- 239000012362 glacial acetic acid Substances 0.000 description 22
- MWFMGBPGAXYFAR-UHFFFAOYSA-N 2-hydroxy-2-methylpropanenitrile Chemical compound CC(C)(O)C#N MWFMGBPGAXYFAR-UHFFFAOYSA-N 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 21
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 19
- 239000003480 eluent Substances 0.000 description 19
- 239000000741 silica gel Substances 0.000 description 19
- 229910002027 silica gel Inorganic materials 0.000 description 19
- 125000004149 thio group Chemical group *S* 0.000 description 19
- 150000001299 aldehydes Chemical class 0.000 description 18
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 18
- 229910001868 water Inorganic materials 0.000 description 18
- WGLUMOCWFMKWIL-UHFFFAOYSA-N dichloromethane;methanol Chemical compound OC.ClCCl WGLUMOCWFMKWIL-UHFFFAOYSA-N 0.000 description 17
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 17
- 238000002360 preparation method Methods 0.000 description 17
- JYKPRQNMODBPRE-UHFFFAOYSA-N 4-hydroxy-2-phenyl-2-(2-phenylethyl)-3h-pyran-6-one Chemical compound C1C(O)=CC(=O)OC1(C=1C=CC=CC=1)CCC1=CC=CC=C1 JYKPRQNMODBPRE-UHFFFAOYSA-N 0.000 description 16
- 101150041968 CDC13 gene Proteins 0.000 description 16
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 16
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 16
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 16
- 238000003818 flash chromatography Methods 0.000 description 16
- KDDFNTSGICCJKF-UHFFFAOYSA-N 4-hydroxy-2,2-diphenyl-3h-pyran-6-one Chemical compound C1C(O)=CC(=O)OC1(C=1C=CC=CC=1)C1=CC=CC=C1 KDDFNTSGICCJKF-UHFFFAOYSA-N 0.000 description 15
- 241000725303 Human immunodeficiency virus Species 0.000 description 15
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 14
- 239000003112 inhibitor Substances 0.000 description 14
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 description 13
- 239000002585 base Substances 0.000 description 11
- 239000010410 layer Substances 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 10
- ROFVKEOGZVNSKN-UHFFFAOYSA-N 5-bromo-4-hydroxy-2,2-diphenyl-3h-pyran-6-one Chemical compound C1C(O)=C(Br)C(=O)OC1(C=1C=CC=CC=1)C1=CC=CC=C1 ROFVKEOGZVNSKN-UHFFFAOYSA-N 0.000 description 10
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 10
- 239000000543 intermediate Substances 0.000 description 10
- 150000002576 ketones Chemical class 0.000 description 10
- 239000011541 reaction mixture Substances 0.000 description 10
- VEXQIMLWUXENQF-UHFFFAOYSA-N 4-hydroxy-2-(3-methylbutyl)-2-phenyl-3h-pyran-6-one Chemical compound C=1C=CC=CC=1C1(CCC(C)C)CC(O)=CC(=O)O1 VEXQIMLWUXENQF-UHFFFAOYSA-N 0.000 description 9
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 9
- 239000012044 organic layer Substances 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- RMVRSNDYEFQCLF-UHFFFAOYSA-N thiophenol Chemical compound SC1=CC=CC=C1 RMVRSNDYEFQCLF-UHFFFAOYSA-N 0.000 description 9
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 8
- 230000000840 anti-viral effect Effects 0.000 description 8
- 239000004305 biphenyl Substances 0.000 description 8
- 239000000872 buffer Substances 0.000 description 8
- 239000002775 capsule Substances 0.000 description 8
- 239000000284 extract Substances 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 7
- 102000035195 Peptidases Human genes 0.000 description 7
- 108091005804 Peptidases Proteins 0.000 description 7
- 239000004365 Protease Substances 0.000 description 7
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 7
- JFDZBHWFFUWGJE-UHFFFAOYSA-N benzonitrile Substances N#CC1=CC=CC=C1 JFDZBHWFFUWGJE-UHFFFAOYSA-N 0.000 description 7
- 239000012267 brine Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 230000005764 inhibitory process Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 7
- 239000003826 tablet Substances 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical group C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 150000007513 acids Chemical class 0.000 description 6
- PASDCCFISLVPSO-UHFFFAOYSA-N benzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1 PASDCCFISLVPSO-UHFFFAOYSA-N 0.000 description 6
- ZKQFHRVKCYFVCN-UHFFFAOYSA-N ethoxyethane;hexane Chemical compound CCOCC.CCCCCC ZKQFHRVKCYFVCN-UHFFFAOYSA-N 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 229960000549 4-dimethylaminophenol Drugs 0.000 description 5
- RPKZKINTMCUJEV-UHFFFAOYSA-N 4-hydroxy-2-phenyl-2,3-dihydropyran-6-one Chemical compound C1C(O)=CC(=O)OC1C1=CC=CC=C1 RPKZKINTMCUJEV-UHFFFAOYSA-N 0.000 description 5
- PAUDLKMUQLCQQL-UHFFFAOYSA-N 4-hydroxy-2-phenyl-5-(2-phenylethyl)-2,3-dihydropyran-6-one Chemical compound O=C1OC(C=2C=CC=CC=2)CC(O)=C1CCC1=CC=CC=C1 PAUDLKMUQLCQQL-UHFFFAOYSA-N 0.000 description 5
- PQOFOXIQCWOYFL-UHFFFAOYSA-N 5-(4-hydroxy-6-oxo-2-phenyl-3h-pyran-2-yl)pentanoic acid Chemical compound C=1C=CC=CC=1C1(CCCCC(=O)O)CC(O)=CC(=O)O1 PQOFOXIQCWOYFL-UHFFFAOYSA-N 0.000 description 5
- ADSZRVGJNUXBQB-UHFFFAOYSA-N 5-bromo-4-hydroxy-2-phenyl-2-(2-phenylethyl)-3h-pyran-6-one Chemical compound C1C(O)=C(Br)C(=O)OC1(C=1C=CC=CC=1)CCC1=CC=CC=C1 ADSZRVGJNUXBQB-UHFFFAOYSA-N 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000010828 elution Methods 0.000 description 5
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 5
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 5
- 235000019341 magnesium sulphate Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- FRASJONUBLZVQX-UHFFFAOYSA-N 1,4-naphthoquinone Chemical compound C1=CC=C2C(=O)C=CC(=O)C2=C1 FRASJONUBLZVQX-UHFFFAOYSA-N 0.000 description 4
- QEDRUXIMTJVXFL-UHFFFAOYSA-N 2-propan-2-ylbenzenethiol Chemical compound CC(C)C1=CC=CC=C1S QEDRUXIMTJVXFL-UHFFFAOYSA-N 0.000 description 4
- ZPSJGADGUYYRKE-UHFFFAOYSA-N 2H-pyran-2-one Chemical class O=C1C=CC=CO1 ZPSJGADGUYYRKE-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 4
- 108010010369 HIV Protease Proteins 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 239000003443 antiviral agent Substances 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 238000004587 chromatography analysis Methods 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- QSRRZKPKHJHIRB-UHFFFAOYSA-N methyl 4-[(2,5-dichloro-4-methylthiophen-3-yl)sulfonylamino]-2-hydroxybenzoate Chemical compound C1=C(O)C(C(=O)OC)=CC=C1NS(=O)(=O)C1=C(Cl)SC(Cl)=C1C QSRRZKPKHJHIRB-UHFFFAOYSA-N 0.000 description 4
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 4
- 125000006239 protecting group Chemical group 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 239000012265 solid product Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 125000001424 substituent group Chemical group 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 150000003573 thiols Chemical class 0.000 description 4
- BESYIRLKYLZBHL-UHFFFAOYSA-N 2-(3-chlorophenyl)-4-hydroxy-2,3-dihydropyran-6-one Chemical compound C1C(O)=CC(=O)OC1C1=CC=CC(Cl)=C1 BESYIRLKYLZBHL-UHFFFAOYSA-N 0.000 description 3
- BKJZKMOTBRSOJM-UHFFFAOYSA-N 2-(3-methylbutyl)-2-phenyl-3h-pyran-6-one Chemical compound C=1C=CC=CC=1C1(CCC(C)C)CC=CC(=O)O1 BKJZKMOTBRSOJM-UHFFFAOYSA-N 0.000 description 3
- MLEKQWLKSLEIEA-UHFFFAOYSA-N 2-(4-tert-butylphenyl)-4-hydroxy-2,3-dihydropyran-6-one Chemical compound C1=CC(C(C)(C)C)=CC=C1C1OC(=O)C=C(O)C1 MLEKQWLKSLEIEA-UHFFFAOYSA-N 0.000 description 3
- PLGNLGVFOGRRRP-UHFFFAOYSA-N 2-[2-(1,3-benzodioxol-5-yl)ethyl]-4-hydroxy-2-phenyl-3h-pyran-6-one Chemical compound C1C(O)=CC(=O)OC1(C=1C=CC=CC=1)CCC1=CC=C(OCO2)C2=C1 PLGNLGVFOGRRRP-UHFFFAOYSA-N 0.000 description 3
- ATRIJCRJIFBNGD-UHFFFAOYSA-N 2-hexyl-4-hydroxy-2-phenyl-3h-pyran-6-one Chemical compound C=1C=CC=CC=1C1(CCCCCC)CC(O)=CC(=O)O1 ATRIJCRJIFBNGD-UHFFFAOYSA-N 0.000 description 3
- GPZXFICWCMCQPF-UHFFFAOYSA-N 2-methylbenzoyl chloride Chemical compound CC1=CC=CC=C1C(Cl)=O GPZXFICWCMCQPF-UHFFFAOYSA-N 0.000 description 3
- BATNPZRNMNBUQG-UHFFFAOYSA-N 2-pentyl-2-phenyl-3h-pyran-6-one Chemical compound C=1C=CC=CC=1C1(CCCCC)CC=CC(=O)O1 BATNPZRNMNBUQG-UHFFFAOYSA-N 0.000 description 3
- VMZCDNSFRSVYKQ-UHFFFAOYSA-N 2-phenylacetyl chloride Chemical compound ClC(=O)CC1=CC=CC=C1 VMZCDNSFRSVYKQ-UHFFFAOYSA-N 0.000 description 3
- PZMSGKRRTOUKEI-UHFFFAOYSA-N 2-propan-2-ylbenzoyl chloride Chemical compound CC(C)C1=CC=CC=C1C(Cl)=O PZMSGKRRTOUKEI-UHFFFAOYSA-N 0.000 description 3
- MGADZUXDNSDTHW-UHFFFAOYSA-N 2H-pyran Chemical compound C1OC=CC=C1 MGADZUXDNSDTHW-UHFFFAOYSA-N 0.000 description 3
- YHOYYHYBFSYOSQ-UHFFFAOYSA-N 3-methylbenzoyl chloride Chemical compound CC1=CC=CC(C(Cl)=O)=C1 YHOYYHYBFSYOSQ-UHFFFAOYSA-N 0.000 description 3
- GINRGFSNHALPNV-UHFFFAOYSA-N 4-hydroxy-2-(4-methylpentyl)-2-phenyl-3h-pyran-6-one Chemical compound C=1C=CC=CC=1C1(CCCC(C)C)CC(O)=CC(=O)O1 GINRGFSNHALPNV-UHFFFAOYSA-N 0.000 description 3
- PPDDEMOYHPQLQW-UHFFFAOYSA-N 4-hydroxy-2-(4-methylphenyl)-2,3-dihydropyran-6-one Chemical compound C1=CC(C)=CC=C1C1OC(=O)C=C(O)C1 PPDDEMOYHPQLQW-UHFFFAOYSA-N 0.000 description 3
- GODAXOHAWOJXQP-UHFFFAOYSA-N 4-hydroxy-2-(4-methylsulfanylphenyl)-2,3-dihydropyran-6-one Chemical compound C1=CC(SC)=CC=C1C1OC(=O)C=C(O)C1 GODAXOHAWOJXQP-UHFFFAOYSA-N 0.000 description 3
- RRJCHYYXHYUPAM-UHFFFAOYSA-N 4-hydroxy-2-phenyl-2-propyl-3h-pyran-6-one Chemical compound C=1C=CC=CC=1C1(CCC)CC(O)=CC(=O)O1 RRJCHYYXHYUPAM-UHFFFAOYSA-N 0.000 description 3
- VNZOLPIHDIJPBZ-UHFFFAOYSA-N 4-hydroxypyran-2-one Chemical class OC=1C=COC(=O)C=1 VNZOLPIHDIJPBZ-UHFFFAOYSA-N 0.000 description 3
- CGIZQEXKNXCECU-UHFFFAOYSA-N 5-bromo-4-hydroxy-2-(3-methylbutyl)-2-phenyl-3h-pyran-6-one Chemical compound C=1C=CC=CC=1C1(CCC(C)C)CC(O)=C(Br)C(=O)O1 CGIZQEXKNXCECU-UHFFFAOYSA-N 0.000 description 3
- OKIJSNGRQAOIGZ-UHFFFAOYSA-N Butopyronoxyl Chemical compound CCCCOC(=O)C1=CC(=O)CC(C)(C)O1 OKIJSNGRQAOIGZ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- WBKFWQBXFREOFH-UHFFFAOYSA-N dichloromethane;ethyl acetate Chemical compound ClCCl.CCOC(C)=O WBKFWQBXFREOFH-UHFFFAOYSA-N 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- 239000002552 dosage form Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003937 drug carrier Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 125000000524 functional group Chemical group 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 3
- 125000000468 ketone group Chemical group 0.000 description 3
- 150000002596 lactones Chemical class 0.000 description 3
- 239000007937 lozenge Substances 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 3
- 125000003261 o-tolyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])C([H])([H])[H] 0.000 description 3
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N phenylbenzene Natural products C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 3
- 235000019260 propionic acid Nutrition 0.000 description 3
- 229920006395 saturated elastomer Polymers 0.000 description 3
- 239000011550 stock solution Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- ILMRJRBKQSSXGY-UHFFFAOYSA-N tert-butyl(dimethyl)silicon Chemical group C[Si](C)C(C)(C)C ILMRJRBKQSSXGY-UHFFFAOYSA-N 0.000 description 3
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 3
- GMSPBQAFPQWFSF-UHFFFAOYSA-N (4-methylphenyl)-oxo-(2-phenoxyethoxy)-sulfanylidene-$l^{6}-sulfane Chemical compound C1=CC(C)=CC=C1S(=O)(=S)OCCOC1=CC=CC=C1 GMSPBQAFPQWFSF-UHFFFAOYSA-N 0.000 description 2
- JCXQFBVGTHAWJU-UHFFFAOYSA-N (4-methylphenyl)-oxo-(3-phenylpropoxy)-sulfanylidene-$l^{6}-sulfane Chemical compound C1=CC(C)=CC=C1S(=O)(=S)OCCCC1=CC=CC=C1 JCXQFBVGTHAWJU-UHFFFAOYSA-N 0.000 description 2
- XHLHPRDBBAGVEG-UHFFFAOYSA-N 1-tetralone Chemical compound C1=CC=C2C(=O)CCCC2=C1 XHLHPRDBBAGVEG-UHFFFAOYSA-N 0.000 description 2
- UOLRPBAZCVYNCW-UHFFFAOYSA-N 2-(4-chlorophenyl)-4-hydroxy-2,3-dihydropyran-6-one Chemical compound C1C(O)=CC(=O)OC1C1=CC=C(Cl)C=C1 UOLRPBAZCVYNCW-UHFFFAOYSA-N 0.000 description 2
- XKGWKCLBRNDYPT-UHFFFAOYSA-N 2-(n-methylanilino)-1-phenylethanone Chemical compound C=1C=CC=CC=1N(C)CC(=O)C1=CC=CC=C1 XKGWKCLBRNDYPT-UHFFFAOYSA-N 0.000 description 2
- LYJBNJHMJBVLHD-UHFFFAOYSA-N 2-butan-2-ylbenzenethiol Chemical compound CCC(C)C1=CC=CC=C1S LYJBNJHMJBVLHD-UHFFFAOYSA-N 0.000 description 2
- OKSSEJLEFLROKY-UHFFFAOYSA-N 2-butyl-4-hydroxy-2-phenyl-3h-pyran-6-one Chemical compound C=1C=CC=CC=1C1(CCCC)CC(O)=CC(=O)O1 OKSSEJLEFLROKY-UHFFFAOYSA-N 0.000 description 2
- ONIKNECPXCLUHT-UHFFFAOYSA-N 2-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1Cl ONIKNECPXCLUHT-UHFFFAOYSA-N 0.000 description 2
- SZIBCPXVPDQAQJ-UHFFFAOYSA-N 3-(4-hydroxy-6-oxo-2-phenyl-3h-pyran-2-yl)propanoic acid Chemical compound C=1C=CC=CC=1C1(CCC(=O)O)CC(O)=CC(=O)O1 SZIBCPXVPDQAQJ-UHFFFAOYSA-N 0.000 description 2
- HSJKGGMUJITCBW-UHFFFAOYSA-N 3-hydroxybutanal Chemical compound CC(O)CC=O HSJKGGMUJITCBW-UHFFFAOYSA-N 0.000 description 2
- WRXOZRLZDJAYDR-UHFFFAOYSA-N 3-methylbenzenethiol Chemical compound CC1=CC=CC(S)=C1 WRXOZRLZDJAYDR-UHFFFAOYSA-N 0.000 description 2
- VOMLYNACJSHEPD-UHFFFAOYSA-N 4-(4-hydroxy-6-oxo-2-phenyl-3h-pyran-2-yl)butanamide Chemical compound C=1C=CC=CC=1C1(CCCC(=O)N)CC(O)=CC(=O)O1 VOMLYNACJSHEPD-UHFFFAOYSA-N 0.000 description 2
- HXLALLXBSZKEFT-UHFFFAOYSA-N 4-hydroxy-2-(2,3,4,5,6-pentafluorophenyl)-2,3-dihydropyran-6-one Chemical compound C1C(O)=CC(=O)OC1C1=C(F)C(F)=C(F)C(F)=C1F HXLALLXBSZKEFT-UHFFFAOYSA-N 0.000 description 2
- OKLHAGUMPJNRBP-UHFFFAOYSA-N 4-hydroxy-2-(2-methylpropyl)-2-phenyl-3h-pyran-6-one Chemical compound C=1C=CC=CC=1C1(CC(C)C)CC(O)=CC(=O)O1 OKLHAGUMPJNRBP-UHFFFAOYSA-N 0.000 description 2
- VWBOVSOURJGOHQ-UHFFFAOYSA-N 4-hydroxy-2-(3-methylphenyl)-2,3-dihydropyran-6-one Chemical compound CC1=CC=CC(C2OC(=O)C=C(O)C2)=C1 VWBOVSOURJGOHQ-UHFFFAOYSA-N 0.000 description 2
- JCMKSWCQULZDKY-UHFFFAOYSA-N 4-hydroxy-2-(4-phenylmethoxyphenyl)-2,3-dihydropyran-6-one Chemical compound C1C(O)=CC(=O)OC1C(C=C1)=CC=C1OCC1=CC=CC=C1 JCMKSWCQULZDKY-UHFFFAOYSA-N 0.000 description 2
- JVKKDZHHKMLILF-UHFFFAOYSA-N 4-hydroxy-2-[(n-methylanilino)methyl]-2-phenyl-3h-pyran-6-one Chemical compound C=1C=CC=CC=1N(C)CC1(C=2C=CC=CC=2)CC(O)=CC(=O)O1 JVKKDZHHKMLILF-UHFFFAOYSA-N 0.000 description 2
- VXIXUWQIVKSKSA-UHFFFAOYSA-N 4-hydroxycoumarin Chemical compound C1=CC=CC2=C1OC(=O)C=C2O VXIXUWQIVKSKSA-UHFFFAOYSA-N 0.000 description 2
- QMOBLCPLNYYWDU-UHFFFAOYSA-N 4-methyl-2-propan-2-ylbenzenethiol Chemical compound CC(C)C1=CC(C)=CC=C1S QMOBLCPLNYYWDU-UHFFFAOYSA-N 0.000 description 2
- OTXINXDGSUFPNU-UHFFFAOYSA-N 4-tert-butylbenzaldehyde Chemical compound CC(C)(C)C1=CC=C(C=O)C=C1 OTXINXDGSUFPNU-UHFFFAOYSA-N 0.000 description 2
- YSNSALYPQQBIDC-UHFFFAOYSA-N 5-(3-chlorophenyl)cyclohexane-1,3-dione Chemical compound ClC1=CC=CC(C2CC(=O)CC(=O)C2)=C1 YSNSALYPQQBIDC-UHFFFAOYSA-N 0.000 description 2
- ZLDJJQHKFQMKSD-UHFFFAOYSA-N 5-bromo-4-hydroxy-2,3-dihydropyran-6-one Chemical compound OC1=C(Br)C(=O)OCC1 ZLDJJQHKFQMKSD-UHFFFAOYSA-N 0.000 description 2
- GDLHZUSLTJYZFX-UHFFFAOYSA-N 5-methyl-1-phenylhexan-1-one Chemical compound CC(C)CCCC(=O)C1=CC=CC=C1 GDLHZUSLTJYZFX-UHFFFAOYSA-N 0.000 description 2
- NQRDWRPSYDFYNE-UHFFFAOYSA-N 5-methyl-2-propan-2-ylbenzenethiol Chemical compound CC(C)C1=CC=C(C)C=C1S NQRDWRPSYDFYNE-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000714197 Avian myeloblastosis-associated virus Species 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- KNSVWMWTSDNKED-UHFFFAOYSA-N C1=CC(C)=CC=C1S(=O)(=S)OCC1=CC=CC(C(F)(F)F)=C1 Chemical compound C1=CC(C)=CC=C1S(=O)(=S)OCC1=CC=CC(C(F)(F)F)=C1 KNSVWMWTSDNKED-UHFFFAOYSA-N 0.000 description 2
- PHFPBKBZYQBSJP-UHFFFAOYSA-N C1=CC(C)=CC=C1S(=O)(=S)OCC1=CC=CC=C1Cl Chemical compound C1=CC(C)=CC=C1S(=O)(=S)OCC1=CC=CC=C1Cl PHFPBKBZYQBSJP-UHFFFAOYSA-N 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- DQFBYFPFKXHELB-UHFFFAOYSA-N Chalcone Natural products C=1C=CC=CC=1C(=O)C=CC1=CC=CC=C1 DQFBYFPFKXHELB-UHFFFAOYSA-N 0.000 description 2
- 241000713800 Feline immunodeficiency virus Species 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 2
- 208000031886 HIV Infections Diseases 0.000 description 2
- 108010078851 HIV Reverse Transcriptase Proteins 0.000 description 2
- 241000713772 Human immunodeficiency virus 1 Species 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AFBPFSWMIHJQDM-UHFFFAOYSA-N N-methylaniline Chemical compound CNC1=CC=CC=C1 AFBPFSWMIHJQDM-UHFFFAOYSA-N 0.000 description 2
- YNPNZTXNASCQKK-UHFFFAOYSA-N Phenanthrene Natural products C1=CC=C2C3=CC=CC=C3C=CC2=C1 YNPNZTXNASCQKK-UHFFFAOYSA-N 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010076039 Polyproteins Proteins 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000714474 Rous sarcoma virus Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 2
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000001350 alkyl halides Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- OVHDZBAFUMEXCX-UHFFFAOYSA-N benzyl 4-methylbenzenesulfonate Chemical compound C1=CC(C)=CC=C1S(=O)(=O)OCC1=CC=CC=C1 OVHDZBAFUMEXCX-UHFFFAOYSA-N 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 150000001789 chalcones Chemical class 0.000 description 2
- 235000005513 chalcones Nutrition 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 229940110456 cocoa butter Drugs 0.000 description 2
- 235000019868 cocoa butter Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- HJSLFCCWAKVHIW-UHFFFAOYSA-N cyclohexane-1,3-dione Chemical class O=C1CCCC(=O)C1 HJSLFCCWAKVHIW-UHFFFAOYSA-N 0.000 description 2
- QGGZBXOADPVUPN-UHFFFAOYSA-N dihydrochalcone Chemical compound C=1C=CC=CC=1C(=O)CCC1=CC=CC=C1 QGGZBXOADPVUPN-UHFFFAOYSA-N 0.000 description 2
- 239000000839 emulsion Substances 0.000 description 2
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 description 2
- 239000011152 fibreglass Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- 239000004030 hiv protease inhibitor Substances 0.000 description 2
- SSBBQNOCGGHKJQ-UHFFFAOYSA-N hydroxy-(4-methylphenyl)-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound CC1=CC=C(S(S)(=O)=O)C=C1 SSBBQNOCGGHKJQ-UHFFFAOYSA-N 0.000 description 2
- VLUWVUMGVPJOIA-UHFFFAOYSA-N hydroxy-(4-methylphenyl)-oxo-sulfanylidene-$l^{6}-sulfane;1-methyl-2-phenylbenzene Chemical compound CC1=CC=C(S(O)(=O)=S)C=C1.CC1=CC=CC=C1C1=CC=CC=C1 VLUWVUMGVPJOIA-UHFFFAOYSA-N 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 2
- 125000000040 m-tolyl group Chemical group [H]C1=C([H])C(*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- BAQGCWNPCFABAY-UHFFFAOYSA-N methyl 2-sulfanylbenzoate Chemical compound COC(=O)C1=CC=CC=C1S BAQGCWNPCFABAY-UHFFFAOYSA-N 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- 229920000609 methyl cellulose Polymers 0.000 description 2
- 239000001923 methylcellulose Substances 0.000 description 2
- 235000010981 methylcellulose Nutrition 0.000 description 2
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 2
- SPQRGFZUSOOCOJ-UHFFFAOYSA-N n-benzyl-5-(4-hydroxy-6-oxo-2-phenyl-3h-pyran-2-yl)pentanamide Chemical compound C1C(O)=CC(=O)OC1(C=1C=CC=CC=1)CCCCC(=O)NCC1=CC=CC=C1 SPQRGFZUSOOCOJ-UHFFFAOYSA-N 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- ZRSNZINYAWTAHE-UHFFFAOYSA-N p-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C=C1 ZRSNZINYAWTAHE-UHFFFAOYSA-N 0.000 description 2
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000001177 retroviral effect Effects 0.000 description 2
- 239000003419 rna directed dna polymerase inhibitor Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 229940124597 therapeutic agent Drugs 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000000844 transformation Methods 0.000 description 2
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 description 2
- 229960005080 warfarin Drugs 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- JCQVMDZXBGBMOG-UHFFFAOYSA-N (2,5-dimethylphenyl)methyl 4-methylbenzenesulfonate Chemical compound C1(=CC=C(C=C1)S(=O)(=O)OCC1=C(C=CC(=C1)C)C)C JCQVMDZXBGBMOG-UHFFFAOYSA-N 0.000 description 1
- SKQHYBKHTJTTJI-UHFFFAOYSA-N (3-methoxyphenyl)methoxy-(4-methylphenyl)-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound COC1=CC=CC(COS(=O)(=S)C=2C=CC(C)=CC=2)=C1 SKQHYBKHTJTTJI-UHFFFAOYSA-N 0.000 description 1
- REVNJYSENNHEKS-UHFFFAOYSA-N (4-methylphenyl)-oxo-[(2-phenylphenyl)methoxy]-sulfanylidene-lambda6-sulfane Chemical compound C1(=CC=CC=C1C1=CC=CC=C1)COS(=O)(=S)C1=CC=C(C=C1)C REVNJYSENNHEKS-UHFFFAOYSA-N 0.000 description 1
- CQLXSFDDEBUZQZ-UHFFFAOYSA-N 1,2-diphenylpropan-1-one Chemical class C=1C=CC=CC=1C(C)C(=O)C1=CC=CC=C1 CQLXSFDDEBUZQZ-UHFFFAOYSA-N 0.000 description 1
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- MAHPVQDVMLWUAG-UHFFFAOYSA-N 1-phenylhexan-1-one Chemical compound CCCCCC(=O)C1=CC=CC=C1 MAHPVQDVMLWUAG-UHFFFAOYSA-N 0.000 description 1
- QYXNLSVBDXZRKC-UHFFFAOYSA-N 2,2-diphenyl-3h-pyran-6-one Chemical compound C1C=CC(=O)OC1(C=1C=CC=CC=1)C1=CC=CC=C1 QYXNLSVBDXZRKC-UHFFFAOYSA-N 0.000 description 1
- QJXCFMJTJYCLFG-UHFFFAOYSA-N 2,3,4,5,6-pentafluorobenzaldehyde Chemical compound FC1=C(F)C(F)=C(C=O)C(F)=C1F QJXCFMJTJYCLFG-UHFFFAOYSA-N 0.000 description 1
- XXVRXBXTJQZLCM-UHFFFAOYSA-N 2-(2-chlorophenyl)-4-hydroxy-2,3-dihydropyran-6-one Chemical compound C1C(O)=CC(=O)OC1C1=CC=CC=C1Cl XXVRXBXTJQZLCM-UHFFFAOYSA-N 0.000 description 1
- BIJDZLUJDGKKNW-UHFFFAOYSA-N 2-(4-methylphenyl)-5-(2-phenylethylsulfanyl)-2,3-dihydropyran-6-one Chemical compound C1=CC(C)=CC=C1C1OC(=O)C(SCCC=2C=CC=CC=2)=CC1 BIJDZLUJDGKKNW-UHFFFAOYSA-N 0.000 description 1
- QPEREQJMHPQPDP-UHFFFAOYSA-N 2-(4-methylsulfanylphenyl)-5-(2-phenylethylsulfanyl)-2,3-dihydropyran-6-one Chemical compound C1=CC(SC)=CC=C1C1OC(=O)C(SCCC=2C=CC=CC=2)=CC1 QPEREQJMHPQPDP-UHFFFAOYSA-N 0.000 description 1
- LUQSZGJFVAYSEF-UHFFFAOYSA-N 2-(cyclopentylmethyl)-4-hydroxy-2-phenyl-3h-pyran-6-one Chemical compound C1C(O)=CC(=O)OC1(C=1C=CC=CC=1)CC1CCCC1 LUQSZGJFVAYSEF-UHFFFAOYSA-N 0.000 description 1
- MXIUWSYTQJLIKE-UHFFFAOYSA-N 2-(trifluoromethyl)benzoyl chloride Chemical compound FC(F)(F)C1=CC=CC=C1C(Cl)=O MXIUWSYTQJLIKE-UHFFFAOYSA-N 0.000 description 1
- DSCJETUEDFKYGN-UHFFFAOYSA-N 2-Methoxybenzenethiol Chemical compound COC1=CC=CC=C1S DSCJETUEDFKYGN-UHFFFAOYSA-N 0.000 description 1
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 1
- HPVWGMVILRRSCN-UHFFFAOYSA-N 2-[2-(3,4-dichlorophenyl)ethyl]-4-hydroxy-2-phenyl-3h-pyran-6-one Chemical compound C1C(O)=CC(=O)OC1(C=1C=CC=CC=1)CCC1=CC=C(Cl)C(Cl)=C1 HPVWGMVILRRSCN-UHFFFAOYSA-N 0.000 description 1
- XVYHEDBFCDWQSD-UHFFFAOYSA-N 2-[2-(4-fluorophenyl)ethyl]-4-hydroxy-2-phenyl-3h-pyran-6-one Chemical compound C1C(O)=CC(=O)OC1(C=1C=CC=CC=1)CCC1=CC=C(F)C=C1 XVYHEDBFCDWQSD-UHFFFAOYSA-N 0.000 description 1
- JJFOBACUIRKUPN-UHFFFAOYSA-N 2-bromoethoxybenzene Chemical compound BrCCOC1=CC=CC=C1 JJFOBACUIRKUPN-UHFFFAOYSA-N 0.000 description 1
- SHONQVFVUVDFNW-UHFFFAOYSA-N 2-butyl-4-hydroxy-2-(4-phenylphenyl)-3h-pyran-6-one Chemical compound C=1C=C(C=2C=CC=CC=2)C=CC=1C1(CCCC)CC(O)=CC(=O)O1 SHONQVFVUVDFNW-UHFFFAOYSA-N 0.000 description 1
- FPYUJUBAXZAQNL-UHFFFAOYSA-N 2-chlorobenzaldehyde Chemical compound ClC1=CC=CC=C1C=O FPYUJUBAXZAQNL-UHFFFAOYSA-N 0.000 description 1
- SNPILNPIIQCQFR-UHFFFAOYSA-N 2-cyclopentyl-1-phenylethanone Chemical compound C=1C=CC=CC=1C(=O)CC1CCCC1 SNPILNPIIQCQFR-UHFFFAOYSA-N 0.000 description 1
- RZNHSEZOLFEFGB-UHFFFAOYSA-N 2-methoxybenzoyl chloride Chemical compound COC1=CC=CC=C1C(Cl)=O RZNHSEZOLFEFGB-UHFFFAOYSA-N 0.000 description 1
- 239000001431 2-methylbenzaldehyde Substances 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- XUXJHBAJZQREDB-UHFFFAOYSA-N 2-methylbutanamide Chemical compound CCC(C)C(N)=O XUXJHBAJZQREDB-UHFFFAOYSA-N 0.000 description 1
- KRSXGTAVHIDVPM-UHFFFAOYSA-N 2-phenoxyacetophenone Chemical compound C=1C=CC=CC=1C(=O)COC1=CC=CC=C1 KRSXGTAVHIDVPM-UHFFFAOYSA-N 0.000 description 1
- ZROLIMSFDJMZMG-UHFFFAOYSA-N 2-phenyl-2-(2-phenylethyl)-3h-pyran-6-one Chemical compound C1C=CC(=O)OC1(C=1C=CC=CC=1)CCC1=CC=CC=C1 ZROLIMSFDJMZMG-UHFFFAOYSA-N 0.000 description 1
- WMPPDTMATNBGJN-UHFFFAOYSA-N 2-phenylethylbromide Chemical compound BrCCC1=CC=CC=C1 WMPPDTMATNBGJN-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- CASRSOJWLARCRX-UHFFFAOYSA-N 3,5-dichlorobenzaldehyde Chemical compound ClC1=CC(Cl)=CC(C=O)=C1 CASRSOJWLARCRX-UHFFFAOYSA-N 0.000 description 1
- DZKJGZPJTGQNDN-UHFFFAOYSA-N 3-(1,3-benzodioxol-5-yl)-1-phenylpropan-1-one Chemical compound C=1C=C2OCOC2=CC=1CCC(=O)C1=CC=CC=C1 DZKJGZPJTGQNDN-UHFFFAOYSA-N 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- CMBSTZZWCGNIQK-UHFFFAOYSA-N 3-(3,4-dichlorophenyl)-1-phenylpropan-1-one Chemical compound C1=C(Cl)C(Cl)=CC=C1CCC(=O)C1=CC=CC=C1 CMBSTZZWCGNIQK-UHFFFAOYSA-N 0.000 description 1
- QLNHWQQSIRBHAT-UHFFFAOYSA-N 3-(4-fluorophenyl)-1-phenylpropan-1-one Chemical compound C1=CC(F)=CC=C1CCC(=O)C1=CC=CC=C1 QLNHWQQSIRBHAT-UHFFFAOYSA-N 0.000 description 1
- YCAIYRWHKSJKEB-UHFFFAOYSA-N 3-(chloromethyl)benzoyl chloride Chemical compound ClCC1=CC=CC(C(Cl)=O)=C1 YCAIYRWHKSJKEB-UHFFFAOYSA-N 0.000 description 1
- HEOVGVNITGAUKL-UHFFFAOYSA-N 3-Methyl-1-phenyl-1-butanone Chemical compound CC(C)CC(=O)C1=CC=CC=C1 HEOVGVNITGAUKL-UHFFFAOYSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- YZULKKFQUIFULV-UHFFFAOYSA-N 3-benzylsulfanyl-6,6-diphenyloxane-2,4-dione Chemical compound O=C1CC(C=2C=CC=CC=2)(C=2C=CC=CC=2)OC(=O)C1SCC1=CC=CC=C1 YZULKKFQUIFULV-UHFFFAOYSA-N 0.000 description 1
- MVPJEKQXGCAIGL-UHFFFAOYSA-N 3-benzylsulfanyl-6-butyl-6-phenyloxane-2,4-dione Chemical compound CCCCC1(CC(=O)C(SCc2ccccc2)C(=O)O1)c1ccccc1 MVPJEKQXGCAIGL-UHFFFAOYSA-N 0.000 description 1
- XMZQWZJMTBCUFT-UHFFFAOYSA-N 3-bromopropylbenzene Chemical compound BrCCCC1=CC=CC=C1 XMZQWZJMTBCUFT-UHFFFAOYSA-N 0.000 description 1
- SRWILAKSARHZPR-UHFFFAOYSA-N 3-chlorobenzaldehyde Chemical compound ClC1=CC=CC(C=O)=C1 SRWILAKSARHZPR-UHFFFAOYSA-N 0.000 description 1
- QMVAZEHZOPDGHA-UHFFFAOYSA-N 3-methoxybenzenethiol Chemical compound COC1=CC=CC(S)=C1 QMVAZEHZOPDGHA-UHFFFAOYSA-N 0.000 description 1
- 125000006497 3-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C(OC([H])([H])[H])=C1[H])C([H])([H])* 0.000 description 1
- 125000004207 3-methoxyphenyl group Chemical group [H]C1=C([H])C(*)=C([H])C(OC([H])([H])[H])=C1[H] 0.000 description 1
- MFEILWXBDBCWKF-UHFFFAOYSA-N 3-phenylpropanoyl chloride Chemical compound ClC(=O)CCC1=CC=CC=C1 MFEILWXBDBCWKF-UHFFFAOYSA-N 0.000 description 1
- TVULAENSWFUDPQ-UHFFFAOYSA-N 4-(4-hydroxy-6-oxo-2-phenyl-3h-pyran-2-yl)butanoic acid Chemical compound C=1C=CC=CC=1C1(CCCC(=O)O)CC(O)=CC(=O)O1 TVULAENSWFUDPQ-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- ILEONPWDYVBXSD-UHFFFAOYSA-N 4-chloro-2-propan-2-ylbenzenethiol Chemical compound CC(C)C1=CC(Cl)=CC=C1S ILEONPWDYVBXSD-UHFFFAOYSA-N 0.000 description 1
- AVPYQKSLYISFPO-UHFFFAOYSA-N 4-chlorobenzaldehyde Chemical compound ClC1=CC=C(C=O)C=C1 AVPYQKSLYISFPO-UHFFFAOYSA-N 0.000 description 1
- WZWIQYMTQZCSKI-UHFFFAOYSA-N 4-cyanobenzaldehyde Chemical compound O=CC1=CC=C(C#N)C=C1 WZWIQYMTQZCSKI-UHFFFAOYSA-N 0.000 description 1
- QDPSJFNSGXBNCF-UHFFFAOYSA-N 4-hydroxy-2,2-diphenyl-5-(2-propan-2-ylphenyl)sulfanyl-3h-pyran-6-one Chemical compound CC(C)C1=CC=CC=C1SC1=C(O)CC(C=2C=CC=CC=2)(C=2C=CC=CC=2)OC1=O QDPSJFNSGXBNCF-UHFFFAOYSA-N 0.000 description 1
- KCZPGCKRXMFLNX-UHFFFAOYSA-N 4-hydroxy-2,2-diphenyl-5-(3-phenylpropyl)-3h-pyran-6-one Chemical compound O=C1OC(C=2C=CC=CC=2)(C=2C=CC=CC=2)CC(O)=C1CCCC1=CC=CC=C1 KCZPGCKRXMFLNX-UHFFFAOYSA-N 0.000 description 1
- JBCJYOQLWYPRAJ-UHFFFAOYSA-N 4-hydroxy-2,2-diphenyl-5-phenylsulfanyl-3h-pyran-6-one Chemical compound O=C1OC(C=2C=CC=CC=2)(C=2C=CC=CC=2)CC(O)=C1SC1=CC=CC=C1 JBCJYOQLWYPRAJ-UHFFFAOYSA-N 0.000 description 1
- SUTGPLKKJRPJJT-UHFFFAOYSA-N 4-hydroxy-2-(3-methylbutyl)-2-phenyl-5-(2-propan-2-ylphenyl)sulfanyl-3h-pyran-6-one Chemical compound O=C1OC(CCC(C)C)(C=2C=CC=CC=2)CC(O)=C1SC1=CC=CC=C1C(C)C SUTGPLKKJRPJJT-UHFFFAOYSA-N 0.000 description 1
- WTBZMXRUPPBURR-UHFFFAOYSA-N 4-hydroxy-2-(4-methoxyphenyl)-2,3-dihydropyran-6-one Chemical compound C1=CC(OC)=CC=C1C1OC(=O)C=C(O)C1 WTBZMXRUPPBURR-UHFFFAOYSA-N 0.000 description 1
- QNWRQXXFWQLKMN-UHFFFAOYSA-N 4-hydroxy-2-(phenoxymethyl)-2-phenyl-3h-pyran-6-one Chemical compound C1C(O)=CC(=O)OC1(C=1C=CC=CC=1)COC1=CC=CC=C1 QNWRQXXFWQLKMN-UHFFFAOYSA-N 0.000 description 1
- QHNFRKWRZDZDST-UHFFFAOYSA-N 4-hydroxy-2-[(4-phenylphenoxy)methyl]-2,3-dihydropyran-6-one Chemical compound C1C(O)=CC(=O)OC1COC1=CC=C(C=2C=CC=CC=2)C=C1 QHNFRKWRZDZDST-UHFFFAOYSA-N 0.000 description 1
- RBRWRTVSNOXJCT-UHFFFAOYSA-N 4-hydroxy-2-pentyl-2-phenyl-3h-pyran-6-one Chemical compound C=1C=CC=CC=1C1(CCCCC)CC(O)=CC(=O)O1 RBRWRTVSNOXJCT-UHFFFAOYSA-N 0.000 description 1
- PJZBCYOHIQNKLV-UHFFFAOYSA-N 4-hydroxy-2-phenyl-2,5-bis(2-phenylethyl)-3h-pyran-6-one Chemical compound O=C1OC(CCC=2C=CC=CC=2)(C=2C=CC=CC=2)CC(O)=C1CCC1=CC=CC=C1 PJZBCYOHIQNKLV-UHFFFAOYSA-N 0.000 description 1
- YEVQHFAZZYDXNY-UHFFFAOYSA-N 4-hydroxy-2-phenyl-2-(2-phenylethyl)-5-[(2-propan-2-ylphenyl)methyl]-3H-pyran-6-one Chemical compound OC1=C(C(OC(C1)(CCC1=CC=CC=C1)C1=CC=CC=C1)=O)CC1=C(C=CC=C1)C(C)C YEVQHFAZZYDXNY-UHFFFAOYSA-N 0.000 description 1
- FIBRYMVJJKPDTM-UHFFFAOYSA-N 4-hydroxy-2-phenyl-2-(2-phenylethyl)-5-phenylsulfanyl-3h-pyran-6-one Chemical compound O=C1OC(CCC=2C=CC=CC=2)(C=2C=CC=CC=2)CC(O)=C1SC1=CC=CC=C1 FIBRYMVJJKPDTM-UHFFFAOYSA-N 0.000 description 1
- XWRNUNTTYHVGCF-UHFFFAOYSA-N 4-hydroxy-2-phenyl-5-(3-phenylpropylsulfanyl)-2,3-dihydropyran-6-one Chemical compound O=C1OC(C=2C=CC=CC=2)CC(O)=C1SCCCC1=CC=CC=C1 XWRNUNTTYHVGCF-UHFFFAOYSA-N 0.000 description 1
- DAGMZKCUYANDQS-UHFFFAOYSA-N 4-hydroxy-5-(2-methoxyphenyl)sulfanyl-2,2-diphenyl-3h-pyran-6-one Chemical compound COC1=CC=CC=C1SC1=C(O)CC(C=2C=CC=CC=2)(C=2C=CC=CC=2)OC1=O DAGMZKCUYANDQS-UHFFFAOYSA-N 0.000 description 1
- QAPFIJTXFWILQG-UHFFFAOYSA-N 4-hydroxy-5-(3-methoxyphenyl)sulfanyl-2,2-diphenyl-3h-pyran-6-one Chemical compound COC1=CC=CC(SC=2C(OC(CC=2O)(C=2C=CC=CC=2)C=2C=CC=CC=2)=O)=C1 QAPFIJTXFWILQG-UHFFFAOYSA-N 0.000 description 1
- LERFOCPDYFGDGY-UHFFFAOYSA-N 4-hydroxy-5-(3-methylbutyl)-2-phenyl-2,3-dihydropyran-6-one Chemical compound O1C(=O)C(CCC(C)C)=C(O)CC1C1=CC=CC=C1 LERFOCPDYFGDGY-UHFFFAOYSA-N 0.000 description 1
- HCZKWXDPTNSOBD-UHFFFAOYSA-N 4-hydroxy-5-(3-methylphenyl)sulfanyl-2,2-diphenyl-3h-pyran-6-one Chemical compound CC1=CC=CC(SC=2C(OC(CC=2O)(C=2C=CC=CC=2)C=2C=CC=CC=2)=O)=C1 HCZKWXDPTNSOBD-UHFFFAOYSA-N 0.000 description 1
- GAUMFXFOSQUPKE-UHFFFAOYSA-N 4-hydroxy-5-(4-methyl-2-propan-2-ylphenyl)sulfanyl-2,2-diphenyl-3h-pyran-6-one Chemical compound CC(C)C1=CC(C)=CC=C1SC1=C(O)CC(C=2C=CC=CC=2)(C=2C=CC=CC=2)OC1=O GAUMFXFOSQUPKE-UHFFFAOYSA-N 0.000 description 1
- FNCQOYGJVCHTBZ-UHFFFAOYSA-N 4-hydroxy-5-(5-methyl-2-propan-2-ylphenyl)sulfanyl-2-phenyl-2-(2-phenylethyl)-3h-pyran-6-one Chemical compound CC(C)C1=CC=C(C)C=C1SC(C(O1)=O)=C(O)CC1(C=1C=CC=CC=1)CCC1=CC=CC=C1 FNCQOYGJVCHTBZ-UHFFFAOYSA-N 0.000 description 1
- FVZRUHGYAWWNNX-UHFFFAOYSA-N 4-hydroxy-5-(naphthalen-1-ylmethyl)-2,2-diphenyl-3h-pyran-6-one Chemical compound C1C(O)=C(CC=2C3=CC=CC=C3C=CC=2)C(=O)OC1(C=1C=CC=CC=1)C1=CC=CC=C1 FVZRUHGYAWWNNX-UHFFFAOYSA-N 0.000 description 1
- JEOCDQKHCXVRGD-UHFFFAOYSA-N 4-hydroxy-5-[(3-methylphenyl)methyl]-2,2-diphenyl-3h-pyran-6-one Chemical compound CC1=CC=CC(CC=2C(OC(CC=2O)(C=2C=CC=CC=2)C=2C=CC=CC=2)=O)=C1 JEOCDQKHCXVRGD-UHFFFAOYSA-N 0.000 description 1
- WRJZDDJYWWJLIS-UHFFFAOYSA-N 4-methyl-1-phenylpentan-1-one Chemical compound CC(C)CCC(=O)C1=CC=CC=C1 WRJZDDJYWWJLIS-UHFFFAOYSA-N 0.000 description 1
- PIMQQGJMDMAZGT-UHFFFAOYSA-N 4-methylthiobenzaldehyde Chemical compound CC1=CC=C(C=S)C=C1 PIMQQGJMDMAZGT-UHFFFAOYSA-N 0.000 description 1
- ISDBWOPVZKNQDW-UHFFFAOYSA-N 4-phenylbenzaldehyde Chemical compound C1=CC(C=O)=CC=C1C1=CC=CC=C1 ISDBWOPVZKNQDW-UHFFFAOYSA-N 0.000 description 1
- ZVTWZSXLLMNMQC-UHFFFAOYSA-N 4-phenylmethoxybenzaldehyde Chemical compound C1=CC(C=O)=CC=C1OCC1=CC=CC=C1 ZVTWZSXLLMNMQC-UHFFFAOYSA-N 0.000 description 1
- ZVRSQAPYZBNWMK-UHFFFAOYSA-N 5-(2-butan-2-ylphenyl)sulfanyl-4-hydroxy-2,2-diphenyl-3h-pyran-6-one Chemical compound CCC(C)C1=CC=CC=C1SC1=C(O)CC(C=2C=CC=CC=2)(C=2C=CC=CC=2)OC1=O ZVRSQAPYZBNWMK-UHFFFAOYSA-N 0.000 description 1
- YLGHVFFSHBLCIP-UHFFFAOYSA-N 5-(2-phenylethylsulfanyl)-2-(4-phenylmethoxyphenyl)-2,3-dihydropyran-6-one Chemical compound O=C1OC(C=2C=CC(OCC=3C=CC=CC=3)=CC=2)CC=C1SCCC1=CC=CC=C1 YLGHVFFSHBLCIP-UHFFFAOYSA-N 0.000 description 1
- WPBVPRBVBJWXDA-UHFFFAOYSA-N 5-(2-phenylethylsulfanyl)-2-(4-phenylphenyl)-2,3-dihydropyran-6-one Chemical compound O=C1OC(C=2C=CC(=CC=2)C=2C=CC=CC=2)CC=C1SCCC1=CC=CC=C1 WPBVPRBVBJWXDA-UHFFFAOYSA-N 0.000 description 1
- DCPFOOHLHOQBCA-UHFFFAOYSA-N 5-(2-phenylethylsulfanyl)-2-[(4-phenylphenoxy)methyl]-2,3-dihydropyran-6-one Chemical compound C1C=C(SCCC=2C=CC=CC=2)C(=O)OC1COC(C=C1)=CC=C1C1=CC=CC=C1 DCPFOOHLHOQBCA-UHFFFAOYSA-N 0.000 description 1
- AHMHROWQGBYDDY-UHFFFAOYSA-N 5-(5-bromo-4-hydroxy-6-oxo-2-phenyl-3h-pyran-2-yl)pentanoic acid Chemical compound C=1C=CC=CC=1C1(CCCCC(=O)O)CC(O)=C(Br)C(=O)O1 AHMHROWQGBYDDY-UHFFFAOYSA-N 0.000 description 1
- GZUKVDZCRLUJRW-UHFFFAOYSA-N 5-[(2-chlorophenyl)methyl]-4-hydroxy-2,2-diphenyl-3h-pyran-6-one Chemical compound O=C1OC(C=2C=CC=CC=2)(C=2C=CC=CC=2)CC(O)=C1CC1=CC=CC=C1Cl GZUKVDZCRLUJRW-UHFFFAOYSA-N 0.000 description 1
- PYVVMPRCHVIHFS-UHFFFAOYSA-N 5-[(2-chlorophenyl)methylsulfanyl]-4-hydroxy-2,2-diphenyl-3h-pyran-6-one Chemical compound O=C1OC(C=2C=CC=CC=2)(C=2C=CC=CC=2)CC(O)=C1SCC1=CC=CC=C1Cl PYVVMPRCHVIHFS-UHFFFAOYSA-N 0.000 description 1
- HZDKELRBALFHQU-UHFFFAOYSA-N 5-[(5,5-dimethyl-3-propan-2-yl-4h-imidazol-2-yl)sulfanyl]-4-hydroxy-2-phenyl-2,3-dihydropyran-6-one Chemical compound CC(C)N1CC(C)(C)N=C1SC1=C(O)CC(C=2C=CC=CC=2)OC1=O HZDKELRBALFHQU-UHFFFAOYSA-N 0.000 description 1
- KPSWQEMGIKNSOZ-UHFFFAOYSA-N 5-[[3-(chloromethyl)phenyl]methyl]-4-hydroxy-2,2-diphenyl-3h-pyran-6-one Chemical compound O=C1OC(C=2C=CC=CC=2)(C=2C=CC=CC=2)CC(O)=C1CC1=CC=CC(CCl)=C1 KPSWQEMGIKNSOZ-UHFFFAOYSA-N 0.000 description 1
- AFTOBSGKQORNJK-UHFFFAOYSA-N 5-benzyl-2-(cyclopentylmethyl)-4-hydroxy-2-phenyl-3h-pyran-6-one Chemical compound O=C1OC(CC2CCCC2)(C=2C=CC=CC=2)CC(O)=C1CC1=CC=CC=C1 AFTOBSGKQORNJK-UHFFFAOYSA-N 0.000 description 1
- JDDUNPPNJKJDTR-UHFFFAOYSA-N 5-benzyl-4-hydroxy-2,2-diphenyl-3h-pyran-6-one Chemical compound O=C1OC(C=2C=CC=CC=2)(C=2C=CC=CC=2)CC(O)=C1CC1=CC=CC=C1 JDDUNPPNJKJDTR-UHFFFAOYSA-N 0.000 description 1
- UATIEXDZINWLEP-UHFFFAOYSA-N 5-benzyl-4-hydroxy-2-pentyl-2-phenyl-3h-pyran-6-one Chemical compound O=C1OC(CCCCC)(C=2C=CC=CC=2)CC(O)=C1CC1=CC=CC=C1 UATIEXDZINWLEP-UHFFFAOYSA-N 0.000 description 1
- RIBJYMDKSDEAAY-UHFFFAOYSA-N 5-benzylsulfanyl-2-(3,5-dichlorophenyl)-4-hydroxy-2,3-dihydropyran-6-one Chemical compound O=C1OC(C=2C=C(Cl)C=C(Cl)C=2)CC(O)=C1SCC1=CC=CC=C1 RIBJYMDKSDEAAY-UHFFFAOYSA-N 0.000 description 1
- APEICFZYXJGYJN-UHFFFAOYSA-N 5-benzylsulfanyl-4-hydroxy-2-(2,3,4,5,6-pentafluorophenyl)-2,3-dihydropyran-6-one Chemical compound O=C1OC(C=2C(=C(F)C(F)=C(F)C=2F)F)CC(O)=C1SCC1=CC=CC=C1 APEICFZYXJGYJN-UHFFFAOYSA-N 0.000 description 1
- XBPDNKFKQDNMPI-UHFFFAOYSA-N 5-benzylsulfanyl-4-hydroxy-2-[4-(trifluoromethyl)phenyl]-2,3-dihydropyran-6-one Chemical compound O=C1OC(C=2C=CC(=CC=2)C(F)(F)F)CC(O)=C1SCC1=CC=CC=C1 XBPDNKFKQDNMPI-UHFFFAOYSA-N 0.000 description 1
- AZBJRELDDRKLRH-UHFFFAOYSA-N 5-bromo-4-hydroxy-3-(3-methylbutyl)-2-phenyl-2,3-dihydropyran-6-one Chemical compound O1C(=O)C(Br)=C(O)C(CCC(C)C)C1C1=CC=CC=C1 AZBJRELDDRKLRH-UHFFFAOYSA-N 0.000 description 1
- KOMXZYGNJSBZSH-UHFFFAOYSA-N 5-oxo-5-phenyl-n-(2-phenylethyl)pentanamide Chemical compound C=1C=CC=CC=1CCNC(=O)CCCC(=O)C1=CC=CC=C1 KOMXZYGNJSBZSH-UHFFFAOYSA-N 0.000 description 1
- SHKWSBAVRQZYLE-UHFFFAOYSA-N 5-oxo-5-phenylpentanoic acid Chemical compound OC(=O)CCCC(=O)C1=CC=CC=C1 SHKWSBAVRQZYLE-UHFFFAOYSA-N 0.000 description 1
- CUWRUSVMGVDZOP-UHFFFAOYSA-N 6-hexyl-6-phenyl-3-(2-phenylethylsulfanyl)oxane-2,4-dione Chemical compound CCCCCCC1(CC(=O)C(SCCc2ccccc2)C(=O)O1)c1ccccc1 CUWRUSVMGVDZOP-UHFFFAOYSA-N 0.000 description 1
- ZHEFOTMDXGMKBT-UHFFFAOYSA-N 6-phenyl-3,4-dihydropyran-2-one Chemical compound O1C(=O)CCC=C1C1=CC=CC=C1 ZHEFOTMDXGMKBT-UHFFFAOYSA-N 0.000 description 1
- HCFFAIZSNVOHSY-UHFFFAOYSA-N 6-phenyl-3-(2-phenylethylsulfanyl)-6-propyloxane-2,4-dione Chemical compound CCCC1(CC(=O)C(SCCc2ccccc2)C(=O)O1)c1ccccc1 HCFFAIZSNVOHSY-UHFFFAOYSA-N 0.000 description 1
- ZZBSGAGBPNDTCX-UHFFFAOYSA-N 6-phenyl-3-(2-phenylethylsulfanyl)oxane-2,4-dione Chemical compound O=C1CC(OC(=O)C1SCCc1ccccc1)c1ccccc1 ZZBSGAGBPNDTCX-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- 108091005502 Aspartic proteases Proteins 0.000 description 1
- 102000035101 Aspartic proteases Human genes 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000219495 Betulaceae Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- YTCVXOAUVXFTDG-UHFFFAOYSA-N C1=CC(C)=CC=C1S(=O)(=S)OCC1=CC=C(OCO2)C2=C1 Chemical compound C1=CC(C)=CC=C1S(=O)(=S)OCC1=CC=C(OCO2)C2=C1 YTCVXOAUVXFTDG-UHFFFAOYSA-N 0.000 description 1
- GQYUDLPOUSPUIJ-UHFFFAOYSA-N C1=CC(C)=CC=C1S(=O)(=S)OCC1=CC=CC2=CC=CC=C12 Chemical compound C1=CC(C)=CC=C1S(=O)(=S)OCC1=CC=CC2=CC=CC=C12 GQYUDLPOUSPUIJ-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical class OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 239000004606 Fillers/Extenders Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 208000037357 HIV infectious disease Diseases 0.000 description 1
- 229940122440 HIV protease inhibitor Drugs 0.000 description 1
- UXMQORVHJMUQFD-UHFFFAOYSA-N Heptanophenone Chemical compound CCCCCCC(=O)C1=CC=CC=C1 UXMQORVHJMUQFD-UHFFFAOYSA-N 0.000 description 1
- 108010016183 Human immunodeficiency virus 1 p16 protease Proteins 0.000 description 1
- 241000713340 Human immunodeficiency virus 2 Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010061598 Immunodeficiency Diseases 0.000 description 1
- 208000029462 Immunodeficiency disease Diseases 0.000 description 1
- 229930194542 Keto Natural products 0.000 description 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000713666 Lentivirus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-L Malonate Chemical compound [O-]C(=O)CC([O-])=O OFOBLEOULBTSOW-UHFFFAOYSA-L 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 238000006174 Newman-Kwart rearrangement reaction Methods 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- 241000276498 Pollachius virens Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 description 1
- 101150085390 RPM1 gene Proteins 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N Valeric acid Natural products CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 1
- 241000112708 Vates Species 0.000 description 1
- 241000282485 Vulpes vulpes Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- IPBVNPXQWQGGJP-UHFFFAOYSA-N acetic acid phenyl ester Natural products CC(=O)OC1=CC=CC=C1 IPBVNPXQWQGGJP-UHFFFAOYSA-N 0.000 description 1
- VXDSLUMUNWTSDB-UHFFFAOYSA-N acetic acid;chloroform;methanol Chemical compound OC.CC(O)=O.ClC(Cl)Cl VXDSLUMUNWTSDB-UHFFFAOYSA-N 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 150000003855 acyl compounds Chemical class 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 125000005236 alkanoylamino group Chemical group 0.000 description 1
- 150000004703 alkoxides Chemical class 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000006177 alkyl benzyl group Chemical group 0.000 description 1
- 125000005037 alkyl phenyl group Chemical group 0.000 description 1
- AEMOLEFTQBMNLQ-BKBMJHBISA-N alpha-D-galacturonic acid Chemical class O[C@H]1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-BKBMJHBISA-N 0.000 description 1
- 238000010640 amide synthesis reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000005557 antagonist Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000036436 anti-hiv Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 229940030600 antihypertensive agent Drugs 0.000 description 1
- 239000002220 antihypertensive agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 159000000032 aromatic acids Chemical class 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- YCOXTKKNXUZSKD-UHFFFAOYSA-N as-o-xylenol Natural products CC1=CC=C(O)C=C1C YCOXTKKNXUZSKD-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- JPYQFYIEOUVJDU-UHFFFAOYSA-N beclamide Chemical compound ClCCC(=O)NCC1=CC=CC=C1 JPYQFYIEOUVJDU-UHFFFAOYSA-N 0.000 description 1
- JUHORIMYRDESRB-UHFFFAOYSA-N benzathine Chemical compound C=1C=CC=CC=1CNCCNCC1=CC=CC=C1 JUHORIMYRDESRB-UHFFFAOYSA-N 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- FFSAXUULYPJSKH-UHFFFAOYSA-N butyrophenone Chemical compound CCCC(=O)C1=CC=CC=C1 FFSAXUULYPJSKH-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- BAQGNDVEQGZTOL-UHFFFAOYSA-N chloro 3-oxobutanoate Chemical compound CC(=O)CC(=O)OCl BAQGNDVEQGZTOL-UHFFFAOYSA-N 0.000 description 1
- KVSASDOGYIBWTA-UHFFFAOYSA-N chloro benzoate Chemical compound ClOC(=O)C1=CC=CC=C1 KVSASDOGYIBWTA-UHFFFAOYSA-N 0.000 description 1
- VDANGULDQQJODZ-UHFFFAOYSA-N chloroprocaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1Cl VDANGULDQQJODZ-UHFFFAOYSA-N 0.000 description 1
- 229960002023 chloroprocaine Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 229940125773 compound 10 Drugs 0.000 description 1
- 238000011443 conventional therapy Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 238000002784 cytotoxicity assay Methods 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- BLEBFDYUDVZRFG-UHFFFAOYSA-N dichloromethane;propan-2-ol Chemical compound ClCCl.CC(C)O BLEBFDYUDVZRFG-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- 229940043237 diethanolamine Drugs 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000003113 dilution method Methods 0.000 description 1
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
- 235000011180 diphosphates Nutrition 0.000 description 1
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000012039 electrophile Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002085 enols Chemical class 0.000 description 1
- 239000002532 enzyme inhibitor Substances 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- XWBDWHCCBGMXKG-UHFFFAOYSA-N ethanamine;hydron;chloride Chemical compound Cl.CCN XWBDWHCCBGMXKG-UHFFFAOYSA-N 0.000 description 1
- UYMKPFRHYYNDTL-UHFFFAOYSA-N ethenamine Chemical compound NC=C UYMKPFRHYYNDTL-UHFFFAOYSA-N 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- GPRDAMCHHGGJNX-UHFFFAOYSA-N ethyl 3-oxo-2-(2-phenylethyl)butanoate Chemical compound CCOC(=O)C(C(C)=O)CCC1=CC=CC=C1 GPRDAMCHHGGJNX-UHFFFAOYSA-N 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012894 fetal calf serum Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-L fumarate(2-) Chemical compound [O-]C(=O)\C=C\C([O-])=O VZCYOOQTPOCHFL-OWOJBTEDSA-L 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940050410 gluconate Drugs 0.000 description 1
- 244000000059 gram-positive pathogen Species 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000003966 growth inhibitor Substances 0.000 description 1
- 125000006277 halobenzyl group Chemical group 0.000 description 1
- 125000005059 halophenyl group Chemical group 0.000 description 1
- 230000002363 herbicidal effect Effects 0.000 description 1
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 208000033519 human immunodeficiency virus infectious disease Diseases 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 1
- 229940071870 hydroiodic acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000007813 immunodeficiency Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- SNHMUERNLJLMHN-UHFFFAOYSA-N iodobenzene Chemical compound IC1=CC=CC=C1 SNHMUERNLJLMHN-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- KQNPFQTWMSNSAP-UHFFFAOYSA-N isobutyric acid Chemical compound CC(C)C(O)=O KQNPFQTWMSNSAP-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- ZLVXBBHTMQJRSX-VMGNSXQWSA-N jdtic Chemical compound C1([C@]2(C)CCN(C[C@@H]2C)C[C@H](C(C)C)NC(=O)[C@@H]2NCC3=CC(O)=CC=C3C2)=CC=CC(O)=C1 ZLVXBBHTMQJRSX-VMGNSXQWSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 1
- OVWYEQOVUDKZNU-UHFFFAOYSA-N m-tolualdehyde Chemical compound CC1=CC=CC(C=O)=C1 OVWYEQOVUDKZNU-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-M mandelate Chemical compound [O-]C(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-M 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910052987 metal hydride Inorganic materials 0.000 description 1
- 150000004681 metal hydrides Chemical class 0.000 description 1
- 125000005341 metaphosphate group Chemical group 0.000 description 1
- WURDRUMOVMHMNY-UHFFFAOYSA-N methyl 2-[[4-hydroxy-6-oxo-2-phenyl-2-(2-phenylethyl)-3h-pyran-5-yl]sulfanyl]benzoate Chemical compound COC(=O)C1=CC=CC=C1SC(C(O1)=O)=C(O)CC1(C=1C=CC=CC=1)CCC1=CC=CC=C1 WURDRUMOVMHMNY-UHFFFAOYSA-N 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- MGJXBDMLVWIYOQ-UHFFFAOYSA-N methylazanide Chemical compound [NH-]C MGJXBDMLVWIYOQ-UHFFFAOYSA-N 0.000 description 1
- 125000002816 methylsulfanyl group Chemical group [H]C([H])([H])S[*] 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- KUBNCWMPFQEWJY-UHFFFAOYSA-N n-benzyl-4-(4-hydroxy-6-oxo-2-phenyl-3h-pyran-2-yl)-n-methylbutanamide Chemical compound C1C(O)=CC(=O)OC1(C=1C=CC=CC=1)CCCC(=O)N(C)CC1=CC=CC=C1 KUBNCWMPFQEWJY-UHFFFAOYSA-N 0.000 description 1
- VERQJIGNRGZHJR-UHFFFAOYSA-N n-benzyl-4-(4-hydroxy-6-oxo-2-phenyl-3h-pyran-2-yl)butanamide Chemical compound C1C(O)=CC(=O)OC1(C=1C=CC=CC=1)CCCC(=O)NCC1=CC=CC=C1 VERQJIGNRGZHJR-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000003136 n-heptyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- RIWRFSMVIUAEBX-UHFFFAOYSA-N n-methyl-1-phenylmethanamine Chemical compound CNCC1=CC=CC=C1 RIWRFSMVIUAEBX-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004923 naphthylmethyl group Chemical group C1(=CC=CC2=CC=CC=C12)C* 0.000 description 1
- 229920003052 natural elastomer Polymers 0.000 description 1
- 229920001194 natural rubber Polymers 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 125000006501 nitrophenyl group Chemical group 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 239000006186 oral dosage form Substances 0.000 description 1
- FXLOVSHXALFLKQ-UHFFFAOYSA-N p-tolualdehyde Chemical compound CC1=CC=C(C=O)C=C1 FXLOVSHXALFLKQ-UHFFFAOYSA-N 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000006201 parenteral dosage form Substances 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- HUPQYPMULVBQDL-UHFFFAOYSA-N pentanoic acid Chemical compound CCCCC(O)=O.CCCCC(O)=O HUPQYPMULVBQDL-UHFFFAOYSA-N 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- LIGACIXOYTUXAW-UHFFFAOYSA-N phenacyl bromide Chemical compound BrCC(=O)C1=CC=CC=C1 LIGACIXOYTUXAW-UHFFFAOYSA-N 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- 229940049953 phenylacetate Drugs 0.000 description 1
- WLJVXDMOQOGPHL-UHFFFAOYSA-N phenylacetic acid Chemical compound OC(=O)CC1=CC=CC=C1 WLJVXDMOQOGPHL-UHFFFAOYSA-N 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- RUDNWZFWWJFUSF-UHFFFAOYSA-M potassium;(4-methylphenyl)-oxido-oxo-sulfanylidene-$l^{6}-sulfane Chemical compound [K+].CC1=CC=C(S([O-])(=O)=S)C=C1 RUDNWZFWWJFUSF-UHFFFAOYSA-M 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 150000003141 primary amines Chemical group 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 238000002976 reverse transcriptase assay Methods 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000003335 secondary amines Chemical group 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- USJDSMARDMUUKE-UHFFFAOYSA-M sodium;4-oxo-4-phenylbutanoate Chemical compound [Na+].[O-]C(=O)CCC(=O)C1=CC=CC=C1 USJDSMARDMUUKE-UHFFFAOYSA-M 0.000 description 1
- ONUQDTBZKQKXNY-UHFFFAOYSA-M sodium;5-oxo-5-phenylpentanoate Chemical compound [Na+].[O-]C(=O)CCCC(=O)C1=CC=CC=C1 ONUQDTBZKQKXNY-UHFFFAOYSA-M 0.000 description 1
- JVWNMDMGMZQAGL-UHFFFAOYSA-M sodium;6-oxo-6-phenylhexanoate Chemical compound [Na+].[O-]C(=O)CCCCC(=O)C1=CC=CC=C1 JVWNMDMGMZQAGL-UHFFFAOYSA-M 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- TYFQFVWCELRYAO-UHFFFAOYSA-L suberate(2-) Chemical compound [O-]C(=O)CCCCCCC([O-])=O TYFQFVWCELRYAO-UHFFFAOYSA-L 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical compound [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 239000005061 synthetic rubber Substances 0.000 description 1
- 239000007885 tablet disintegrant Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000001412 tetrahydropyranyl group Chemical group 0.000 description 1
- WROMPOXWARCANT-UHFFFAOYSA-N tfa trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F.OC(=O)C(F)(F)F WROMPOXWARCANT-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000004001 thioalkyl group Chemical group 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- 125000000026 trimethylsilyl group Chemical group [H]C([H])([H])[Si]([*])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- XKGLSKVNOSHTAD-UHFFFAOYSA-N valerophenone Chemical compound CCCCC(=O)C1=CC=CC=C1 XKGLSKVNOSHTAD-UHFFFAOYSA-N 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 244000052613 viral pathogen Species 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 239000011345 viscous material Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/22—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/86—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/32—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/96—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings spiro-condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15544393A | 1993-11-19 | 1993-11-19 | |
US08/319,820 US5840751A (en) | 1993-11-19 | 1994-10-12 | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
PCT/US1994/012269 WO1995014012A1 (en) | 1993-11-19 | 1994-10-26 | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
Publications (3)
Publication Number | Publication Date |
---|---|
NO962017D0 NO962017D0 (no) | 1996-05-15 |
NO962017L NO962017L (no) | 1996-07-08 |
NO316172B1 true NO316172B1 (no) | 2003-12-22 |
Family
ID=26852338
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19962017A NO316172B1 (no) | 1993-11-19 | 1996-05-15 | 5,6-dihydropyron-derivater og farmasöytisk blanding |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0729464A1 (ru) |
JP (1) | JP3684426B2 (ru) |
AT (1) | ATE263761T1 (ru) |
AU (1) | AU689158B2 (ru) |
CA (1) | CA2176043A1 (ru) |
DE (1) | DE69433705T2 (ru) |
DK (1) | DK1142887T3 (ru) |
ES (1) | ES2219457T3 (ru) |
FI (1) | FI962022A (ru) |
HR (1) | HRP940935B1 (ru) |
HU (1) | HUT77668A (ru) |
IL (1) | IL111674A0 (ru) |
NO (1) | NO316172B1 (ru) |
NZ (1) | NZ275961A (ru) |
PT (1) | PT1142887E (ru) |
RU (1) | RU2140917C1 (ru) |
SI (1) | SI1142887T1 (ru) |
WO (1) | WO1995014012A1 (ru) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69636130T2 (de) * | 1995-08-11 | 2006-12-07 | Zenon Environmental Inc., Oakville | Permeatsammelsystem |
US5834506A (en) * | 1996-11-01 | 1998-11-10 | Warner-Lambert Company | Dihydropyrones with improved antiviral activity |
EP1015441B1 (en) * | 1997-09-11 | 2004-05-12 | PHARMACIA & UPJOHN COMPANY | Process to produce 4-hydroxy-2-oxo-pyrane derivatives useful as protease inhibitors |
WO2000015634A2 (en) * | 1998-09-11 | 2000-03-23 | Warner-Lambert Company | Hiv protease inhibitors |
US6288235B1 (en) | 1999-04-14 | 2001-09-11 | Ortho-Mcneil Pharmaceutical, Inc. | Methods for the synthesis of highly substituted 2,4-dioxopiperidine libraries |
DE10030094A1 (de) * | 2000-06-19 | 2001-12-20 | Bayer Ag | Phenylsubstituierte 5,6-Dihydro-pyron-Derivate |
US6710058B2 (en) | 2000-11-06 | 2004-03-23 | Bristol-Myers Squibb Pharma Company | Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
US7141681B2 (en) | 2001-02-22 | 2006-11-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Continuous process for preparing dihydropyrones |
US6500963B2 (en) | 2001-02-22 | 2002-12-31 | Boehringer Ingelheim Pharma Kg | Process for preparing optically active dihydropyrones |
DE10108470A1 (de) * | 2001-02-22 | 2002-09-05 | Boehringer Ingelheim Pharma | Verfahren zur Herstellung optisch aktiver Dihydropyrone |
DE10108471C1 (de) | 2001-02-22 | 2002-11-21 | Boehringer Ingelheim Pharma | Kontinuierliches Verfahren zur Herstellung von 5,6-Dihydro-4-hydroxy-2-pyronen |
TW200307667A (en) | 2002-05-06 | 2003-12-16 | Bristol Myers Squibb Co | Sulfonylaminovalerolactams and derivatives thereof as factor Xa inhibitors |
DOP2003000641A (es) | 2002-05-10 | 2003-11-15 | Pfizer | Inhibidores de las arn polimerasa dependiente de arn del virus de las hepatitis c y composiciones y tratamiento que los usan |
US7148226B2 (en) | 2003-02-21 | 2006-12-12 | Agouron Pharmaceuticals, Inc. | Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the same |
AP2313A (en) | 2004-08-18 | 2011-10-31 | Pfizer | Inhibitors of hepatitis C virus RNA-dependent RNA ploymerase, and compositions and treatments using the same. |
DE102005059469A1 (de) | 2005-12-13 | 2007-06-14 | Bayer Cropscience Ag | Insektizide Zusammensetzungen mit verbesserter Wirkung |
DE102006007882A1 (de) | 2006-02-21 | 2007-08-30 | Bayer Cropscience Ag | Cycloalkyl-phenylsubstituierte cyclische Ketoenole |
EP2032551B9 (en) * | 2006-06-16 | 2012-02-29 | Pharma Mar, S.A. | Antitumoral dihydropyran-2-one compounds |
MX2011009188A (es) | 2009-03-11 | 2011-09-26 | Bayer Cropscience Ag | Cetoenoles sustituidos con haloalquilmetilenoxi-fenilo. |
DE102010008644A1 (de) | 2010-02-15 | 2011-08-18 | Bayer Schering Pharma Aktiengesellschaft, 13353 | Zyklische Ketoenole zur Therapie |
RU2461555C1 (ru) * | 2011-07-07 | 2012-09-20 | Государственное образовательное учреждение высшего профессионального образования "Пермский государственный университет" | Способ получения 5-арил-3-фенил-2-оксаспиро[5,6]додец-3-ен-1-онов, проявляющих анальгетическую активность |
MX355158B (es) | 2012-01-26 | 2018-04-06 | Bayer Ip Gmbh | Cetaenoles sustituidos con fenilo para controlar parasitos en peces. |
AR093634A1 (es) | 2012-11-28 | 2015-06-17 | Sumitomo Chemical Co | Compuestos de dihidropirona y herbicidas que los comprenden |
SE539512C2 (sv) * | 2015-12-02 | 2017-10-03 | Ultupharma Ab | Compounds and methods of treating bacterial infections |
CN115916752A (zh) * | 2020-06-26 | 2023-04-04 | 日本农药株式会社 | 芳基四氢吡啶衍生物或其盐类、和含有该化合物的杀虫剂及其使用方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3818046A (en) * | 1972-12-18 | 1974-06-18 | Dow Chemical Co | Sulfur-containing hydroxy pyrones and alkali metal salts thereof |
ZA938019B (en) * | 1992-11-13 | 1995-04-28 | Upjohn Co | Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating HIV and other retroviruses |
-
1994
- 1994-10-26 JP JP51445895A patent/JP3684426B2/ja not_active Expired - Fee Related
- 1994-10-26 HU HU9601348A patent/HUT77668A/hu not_active Application Discontinuation
- 1994-10-26 RU RU96113098/04A patent/RU2140917C1/ru not_active IP Right Cessation
- 1994-10-26 CA CA002176043A patent/CA2176043A1/en not_active Abandoned
- 1994-10-26 ES ES01114943T patent/ES2219457T3/es not_active Expired - Lifetime
- 1994-10-26 AT AT01114943T patent/ATE263761T1/de not_active IP Right Cessation
- 1994-10-26 DE DE69433705T patent/DE69433705T2/de not_active Expired - Fee Related
- 1994-10-26 DK DK01114943T patent/DK1142887T3/da active
- 1994-10-26 NZ NZ275961A patent/NZ275961A/en unknown
- 1994-10-26 SI SI9430463T patent/SI1142887T1/xx unknown
- 1994-10-26 AU AU81256/94A patent/AU689158B2/en not_active Ceased
- 1994-10-26 WO PCT/US1994/012269 patent/WO1995014012A1/en not_active Application Discontinuation
- 1994-10-26 PT PT01114943T patent/PT1142887E/pt unknown
- 1994-10-26 EP EP95900429A patent/EP0729464A1/en not_active Withdrawn
- 1994-11-17 HR HR940935A patent/HRP940935B1/xx not_active IP Right Cessation
- 1994-11-17 IL IL11167494A patent/IL111674A0/xx unknown
-
1996
- 1996-05-13 FI FI962022A patent/FI962022A/fi unknown
- 1996-05-15 NO NO19962017A patent/NO316172B1/no not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IL111674A0 (en) | 1995-01-24 |
EP0729464A1 (en) | 1996-09-04 |
HRP940935A2 (en) | 1997-04-30 |
HRP940935B1 (en) | 2004-08-31 |
FI962022A (fi) | 1996-07-12 |
AU689158B2 (en) | 1998-03-26 |
DE69433705D1 (de) | 2004-05-13 |
JP3684426B2 (ja) | 2005-08-17 |
PT1142887E (pt) | 2004-08-31 |
NZ275961A (en) | 2001-11-30 |
DE69433705T2 (de) | 2005-03-10 |
JPH09505294A (ja) | 1997-05-27 |
CA2176043A1 (en) | 1995-05-26 |
ATE263761T1 (de) | 2004-04-15 |
NO962017L (no) | 1996-07-08 |
SI1142887T1 (en) | 2004-08-31 |
HU9601348D0 (en) | 1996-07-29 |
HUT77668A (hu) | 1998-07-28 |
AU8125694A (en) | 1995-06-06 |
NO962017D0 (no) | 1996-05-15 |
ES2219457T3 (es) | 2004-12-01 |
RU2140917C1 (ru) | 1999-11-10 |
DK1142887T3 (da) | 2004-06-21 |
WO1995014012A1 (en) | 1995-05-26 |
FI962022A0 (fi) | 1996-05-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO316172B1 (no) | 5,6-dihydropyron-derivater og farmasöytisk blanding | |
EP1142887B1 (en) | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents | |
AU680064B2 (en) | 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents | |
KR100447557B1 (ko) | 프로테아제억제제및항바이러스제로서의5,6-디히드로피론유도체 | |
KR100441361B1 (ko) | 프로테아제억제제및항바이러스제로서의5,6-디히드로피론유도체 | |
AU687465B2 (en) | Pyrone derivatives as protease inhibitors and antiviral agents | |
SK63996A3 (en) | Pyrone derivatives as protease inhibitors and antiviral agents |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |